Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Higher Response For Gleevec In Trial; CML Patients Allowed To Switch
This article is from
The Cancer Letter
archive.
Vol. 25 No. 1 | January 25, 2002
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Abstracts Of Papers Presented By Breast Cancer Task Force
September 17, 1976
TCL Archive
Gleevec First Pediatric Cancer Approval By FDA In 13 Years
May 30, 2003
TCL Archive
Radium-233 Dichloride Increased Overall Survival in Phase III Trial
June 29, 2012
TCL Archive
CDC Offers Funds For 5-A-Day Program; CDC PA Available
May 14, 1999
TCL Archive
Cancer Advocates Use Benefit Analysis To Press For Funds
May 11, 1990
TCL Archive
ICCCR Issues RFP For Cancer Risk Scale
March 6, 1992